We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.29T
AUM Growth
-$219M
(-0.01%)
Cap. Flow
+$31.2B
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
14.44%
Holding
4,163
New
99
Increased
2,949
Reduced
960
Closed
63
Avg Time Held
3.9
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.53B |
| 2 |
American Tower
AMT
|
+$1.49B |
| 3 |
McDonald's
MCD
|
+$1.13B |
| 4 |
Crown Castle
CCI
|
+$1.07B |
| 5 |
Alibaba
BABA
|
+$970M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$762M |
| 2 |
Amgen
AMGN
|
+$595M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$497M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$468M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$427M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.91% |
| 2 | Financials | 16.33% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 10.89% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
AudioCodes
AUDC
$273M
| $3.24M | ﹤0.01% |
453,564
+8,298
| +2% | +$62K |
2015 Q1
12 quarters
|
|
3302
Tucows
TCX
$117M
| $3.23M | ﹤0.01% |
57,737
+1,733
| +3% | +$97.5K |
2017 Q2
3 quarters
|
|
3303
Talphera
TLPH
$55.5M
| $3.22M | ﹤0.01% |
76,597
-1,075
| -1% | -$42.4K |
2013 Q2
19 quarters
|
|
|
CWAY
3304
DELISTED
Coastway Bancorp, Inc.
CWAY
| $3.19M | ﹤0.01% |
117,067
+29,939
| +34% | +$685K |
2014 Q1
16 quarters
|
|
|
OMED
3305
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $3.19M | ﹤0.01% |
1,001,885
+3,738
| +0.4% | +$10.3K |
2013 Q3
18 quarters
|
|
3306
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.17M | ﹤0.01% |
33,326
+4,383
| +15% | +$752K |
2013 Q2
19 quarters
|
|
|
TIS
3307
DELISTED
Orchids Paper Products, Inc.
TIS
| $3.16M | ﹤0.01% |
387,819
+39,786
| +11% | +$480K |
2013 Q2
19 quarters
|
|
3308
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $3.14M | ﹤0.01% |
214,677
-8,636
| -4% | -$145K |
2013 Q2
19 quarters
|
|
3309
Pulse Biosciences
PLSE
$3.25B
| $3.13M | ﹤0.01% |
231,378
+6,738
| +3% | +$128K |
2016 Q4
5 quarters
|
|
3310
Vanguard Information Technology ETF
VGT
$150B
| $3.13M | ﹤0.01% |
146,200
-1,408
| -1% | -$30.7K |
2014 Q1
16 quarters
|
|
3311
Apyx Medical
APYX
$108M
| $3.12M | ﹤0.01% |
1,049,293
+33,451
| +3% | +$86.1K |
2013 Q2
19 quarters
|
|
3312
Funko
FNKO
$382M
| $3.11M | ﹤0.01% |
379,227
+27,141
| +8% | +$203K |
2017 Q4
1 quarter
|
|
3313
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $3.1M | ﹤0.01% |
80,504
-2,740
| -3% | -$108K |
2013 Q2
19 quarters
|
|
|
SITO
3314
DELISTED
SITO MOBILE, LTD
SITO
| $3.1M | ﹤0.01% |
771,944
+5,315
| +0.7% | +$28.8K |
2015 Q3
10 quarters
|
|
3315
Townsquare Media
TSQ
$70.9M
| $3.1M | ﹤0.01% |
391,113
-11,789
| -3% | -$86.6K |
2014 Q3
14 quarters
|
|
|
ARTX
3316
DELISTED
Arotech Corporation
ARTX
| $3.08M | ﹤0.01% |
1,011,612
| – | – |
2013 Q2
19 quarters
|
|
|
SQBG
3317
DELISTED
Sequential Brands Group, Inc.
SQBG
| $3.08M | ﹤0.01% |
36,957
+1,510
| +4% | +$118K |
2014 Q2
15 quarters
|
|
3318
Fluent
FLNT
$84.1M
| $3.08M | ﹤0.01% |
205,332
+21,663
| +12% | +$470K |
2016 Q1
8 quarters
|
|
3319
Full House Resorts
FLL
$39.6M
| $3.08M | ﹤0.01% |
958,278
-73,235
| -7% | -$243K |
2013 Q2
19 quarters
|
|
3320
Ultralife
ULBI
$102M
| $3.08M | ﹤0.01% |
307,493
+19,867
| +7% | +$154K |
2013 Q2
19 quarters
|
|
|
ALBO
3321
DELISTED
Albireo Pharma Inc
ALBO
| $3.04M | ﹤0.01% |
93,281
+62,262
| +201% | +$2.1M |
2013 Q2
19 quarters
|
|
3322
Lite Strategy Inc
LITS
$36.5M
| $3.02M | ﹤0.01% |
73,061
-362
| -0.5% | -$15.8K |
2013 Q2
19 quarters
|
|
|
INXN
3323
DELISTED
Interxion Holding N.V.
INXN
| $3.02M | ﹤0.01% |
48,662
+9,464
| +24% | +$565K |
2015 Q4
9 quarters
|
|
3324
DELISTED
BioXcel Therapeutics
BTAI
| $3.02M | ﹤0.01% |
+18,438
| New | +$3.08M |
2018 Q1
0 quarters
|
|
3325
DELISTED
Isramco Inc
ISRL
| $3M | ﹤0.01% |
28,855
+94
| +0.3% | +$9.88K |
2013 Q2
19 quarters
|
|
Similar funds
Vanguard Group's Q1 2018 Portfolio in Review
As of Q1 2018, Vanguard Group held 4,163 positions worth $2.29T, down 0.01% from $2.29T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.9%. Vanguard Group opened 99 new positions and exited 63, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2018 buy was Nutrien: 16,386,239 shares worth $774M.
- Vanguard Group added most to Walmart Inc in Q1 2018, an estimated $1.53B increase.
- Vanguard Group's biggest Q1 2018 reduction was Amgen, cutting an estimated $595M.
- Vanguard Group fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $762M.
- Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q1 2018.
- Vanguard Group opened 99 new positions and closed 63 in Q1 2018.
- Vanguard Group's portfolio value fell 0.01% quarter-over-quarter to $2.29T.
Based on Vanguard Group's 13F filing for Q1 2018, filed 15 May 2018.